Nancy T. Sklarin

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

Medicine, Oncology, Pharmacology +17

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by <i>HER2</i> Immunophenotype and Gene Amplification

Andrew D. Seidman, Monica Fornier, Francisco J. Esteva et al. · Journal of Clinical Oncology · 2001 · 550 citations

Medicine, Oncology, Pharmacology +17

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

Medicine, Oncology, Pharmacology +16

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

Catherine Van Poznak, Andrew D. Seidman, Marcus M. Reidenberg et al. · Breast Cancer Research and Treatment · 2001 · 221 citations

Medicine, Oncology, Pharmacology +11

Metastatic Lobular Carcinoma of the Breast

Corinne Winston, Orna Hadar, Jerrold B. Teitcher et al. · American Journal of Roentgenology · 2000 · 151 citations

Medicine, Oncology, Radiology +17